Biogenesis Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-01-2025
- Paid Up Capital ₹ 0.10 M
as on 10-01-2025
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 34.14%
(FY 2022)
- Profit 41.52%
(FY 2022)
- Ebitda 41.72%
(FY 2022)
- Net Worth -100.37%
(FY 2022)
- Total Assets -5.66%
(FY 2022)
About Biogenesis Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sushanta Sen, Inderjeet Mehta, and Manju Udawat serve as directors at the Company.
- CIN/LLPIN
U85100DL2014PTC268293
- Company No.
268293
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biogenesis Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushanta Sen  | Additional Director | 22-Oct-2016 | Current |
| Inderjeet Mehta | Director | 08-Sep-2016 | Current |
| Manju Udawat | Director | 26-Jun-2014 | Current |
Financial Performance of Biogenesis Healthcare.
Biogenesis Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.14% increase. The company also saw a substantial improvement in profitability, with a 41.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 100.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biogenesis Healthcare?
In 2022, Biogenesis Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medicon Biochem Private LimitedActive 1 year 6 monthsSushanta Sen, Inderjeet Mehta and 1 more are mutual person
- Easyindia Compliance Services Private LimitedActive 7 years 10 months
Manju Udawat is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biogenesis Healthcare?
Unlock and access historical data on people associated with Biogenesis Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogenesis Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenesis Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
